The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Methylated circulating tumor DNA (Met-DNA) as an independent prognostic factor in metastatic pancreatic adenocarcinoma (mPAC) patients.
 
Daniel Pietrasz
No Relationships to Disclose
 
Shufang Wang-Renault
Research Funding - SERVIER
 
Laetitia Dahan
Honoraria - Amgen; Sanofi
 
Julien Taieb
Consulting or Advisory Role - Amgen; Baxalta; Celgene; Lilly; Merck KGaA; MSD; Roche; SERVIER; Sirtex Medical
Speakers' Bureau - Amgen; Baxalta; Lilly; Merck; MSD; Roche/Genentech; Sanofi; SERVIER
 
Karine Le Malicot
No Relationships to Disclose
 
Yves Rinaldi
No Relationships to Disclose
 
Solene Doat
Honoraria - Amgen; Merck Serono; MSD
Consulting or Advisory Role - Merck Serono
Expert Testimony - Merck Serono
Travel, Accommodations, Expenses - Merck Serono; SERVIER
 
Jean-Marc Phelip
Consulting or Advisory Role - Amgen; Bayer; Ipsen; Lilly; Merck; Novartis; Roche; Sanofi; SERVIER
Travel, Accommodations, Expenses - Amgen; Bayer; Ipsen; Lilly; Merck; Novartis; Roche; Sanofi; SERVIER
 
Valerie Taly
Research Funding - SERVIER
 
Jean-Baptiste Bachet
Honoraria - Amgen; Bayer; Celgene; Merck Serono; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Merck Serono; Servier
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche; Servier
 
Pierre Laurent-Puig
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Merck; Merck Serono; Roche; Sanofi
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Merck
Patents, Royalties, Other Intellectual Property - Inventor of mir31-3p licence to integragen
Travel, Accommodations, Expenses - Merck; Roche